Trial Profile
Prospective study investigating the lesion morphology after Everolimus eluting stent (EES) implantation in patients with ST-segment elevation myocardial infarction (STEMI) and stable angina (SAP)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Angina pectoris; Myocardial infarction
- Focus Pharmacodynamics; Therapeutic Use
- 31 Dec 2015 New trial record